GBIO vs TXT · rev $19.9M vs P/E 19, rev $7.52B
Generation Bio Co (GBIO) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Generation Bio Co (GBIO) is a biotechnology company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported GBIO revenue for 2024-12-31 was $19.9M. Net income was -$131.7M. Revenue was up 236.9% from 2023-12-31 to 2024-12-31. GBIO currently screens at market cap $25.4M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
GBIO currently screens at market cap $25.4M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the GBIO and TXT stock pages for the full models.
Not investment advice.